Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis
Condition: Lymphatic Filariasis Interventions: Drug: 3 drug dose - IDA; Drug: 2 drug dose - DA Sponsors: Washington University School of Medicine; Case Western Reserve University; Indian Council of Medical Research Active, not recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2016 Category: Research Source Type: clinical trials
Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis
Condition: Lymphatic Filariasis Intervention: Drug: 3 drug dose - IDA Sponsors: Washington University School of Medicine; Case Western Reserve University; Indian Council of Medical Research Active, not recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2016 Category: Research Source Type: clinical trials
Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis
Condition: Lymphatic Filariasis Interventions: Drug: 3 drug dose - IDA; Drug: 2 drug dose - DA Sponsors: Washington University School of Medicine; Case Western Reserve University; Indian Council of Medical Research Active, not recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2016 Category: Research Source Type: clinical trials
Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis
Condition: Lymphatic Filariasis Intervention: Drug: 3 drug dose - IDA Sponsors: Washington University School of Medicine; Case Western Reserve University; Indian Council of Medical Research Active, not recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2016 Category: Research Source Type: clinical trials
Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis
Condition: Lymphatic Filariasis Interventions: Drug: 3 drug dose - IDA; Drug: 2 drug dose - DA Sponsors: Washington University School of Medicine; Case Western Reserve University; Indian Council of Medical Research Active, not recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2016 Category: Research Source Type: clinical trials
Optimization of MDA With Existing Drug Regimens for LF: Monitoring Efficacy of Ongoing Treatment Programs in PNG
Condition: Lymphatic Filariasis Intervention: Sponsors: University Hospitals Cleveland Medical Center; Papua New Guinea Institute of Medical Research Recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 28, 2013 Category: Research Source Type: clinical trials